Author: Dr Parto Toofan

Dr Parto Toofan
Study Director, REPROCELL Europe

Using human iPSCs as an in vitro model for regenerative medicine, drug screening and disease modelling

In translational medicine, research using primary patient samples is advantageous over cell lines as the expression of the protein under investigation is regulated by native elements in primary samples.

Continue reading